Acuson (US) unveils new transducer:
This article was originally published in Clinica
Acuson (US) unveiled V4C microCase, its new cardiac imaging transducer, at the American Society of Echocardiography, in Toronto, Canada (June 14th-16th). The transducer is intended for transthoracic stress-test imaging. It switches between three frequencies - 4, 3.5 and 2.5 MHz - which allows it to image adults with tight rib spacing, by reducing shadowing. Acuson says the ergonomics of the V4C make it easier to manipulate and a smaller rounder tip makes switching between views much simpler.
You may also be interested in...
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.